Soleno
  • Company
    • Management
    • Board
    • Advisors
    • Careers
  • Product Candidate
    • DCCR
    • Mode of Action
    • Completed Studies
    • Clinical Trials
  • For Patients
    • Prader-Willi Syndrome
    • Patient Access
  • Investors
  • Contact us

Clinical References form

    Developing novel therapeutics for the treatment of rare diseases.

    Pages

    • Company
      • Management
      • Boards
      • Advisors
      • Careers
    • For Patients
      • Prader-Willi Syndrome
    • Investors
    • Contact us

    News and Events

    Soleno Therapeutics Announces Peer-Reviewed Publication of Results from Previously Completed Phase 3 Trial of DCCR for Treatment of Prader-Willi Syndrome

    Soleno Therapeutics Announces Financing Commitment for up to $60 Million

    Contact Us

    • 203 Redwood Shores Parkway
    • Suite 500
    • Redwood City, CA 94065
    • Tel: (650) 213-8444
    • Email: info@soleno.life
    • Find us on Facebook

    Soleno Therapeutics, Inc. © 2023 | All Rights Reserved

    • Terms of Use
    • Privacy Statement
    • Customer Support